| UniProt ID | K22E_HUMAN | |
|---|---|---|
| UniProt AC | P35908 | |
| Protein Name | Keratin, type II cytoskeletal 2 epidermal | |
| Gene Name | KRT2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 639 | |
| Subcellular Localization | ||
| Protein Description | Probably contributes to terminal cornification. [PubMed: 1380918 Associated with keratinocyte activation, proliferation and keratinization] | |
| Protein Sequence | MSCQISCKSRGRGGGGGGFRGFSSGSAVVSGGSRRSTSSFSCLSRHGGGGGGFGGGGFGSRSLVGLGGTKSISISVAGGGGGFGAAGGFGGRGGGFGGGSSFGGGSGFSGGGFGGGGFGGGRFGGFGGPGGVGGLGGPGGFGPGGYPGGIHEVSVNQSLLQPLNVKVDPEIQNVKAQEREQIKTLNNKFASFIDKVRFLEQQNQVLQTKWELLQQMNVGTRPINLEPIFQGYIDSLKRYLDGLTAERTSQNSELNNMQDLVEDYKKKYEDEINKRTAAENDFVTLKKDVDNAYMIKVELQSKVDLLNQEIEFLKVLYDAEISQIHQSVTDTNVILSMDNSRNLDLDSIIAEVKAQYEEIAQRSKEEAEALYHSKYEELQVTVGRHGDSLKEIKIEISELNRVIQRLQGEIAHVKKQCKNVQDAIADAEQRGEHALKDARNKLNDLEEALQQAKEDLARLLRDYQELMNVKLALDVEIATYRKLLEGEECRMSGDLSSNVTVSVTSSTISSNVASKAAFGGSGGRGSSSGGGYSSGSSSYGSGGRQSGSRGGSGGGGSISGGGYGSGGGSGGRYGSGGGSKGGSISGGGYGSGGGKHSSGGGSRGGSSSGGGYGSGGGGSSSVKGSSGEAFGSSVTFSFR | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 12 | Methylation | ISCKSRGRGGGGGGF EEECCCCCCCCCCCC | 39.20 | - | |
| 20 | Asymmetric dimethylarginine | GGGGGGFRGFSSGSA CCCCCCCCCCCCCCE | 48.82 | - | |
| 20 | Methylation | GGGGGGFRGFSSGSA CCCCCCCCCCCCCCE | 48.82 | - | |
| 23 | Phosphorylation | GGGFRGFSSGSAVVS CCCCCCCCCCCEEEE | 36.29 | - | |
| 24 | Phosphorylation | GGFRGFSSGSAVVSG CCCCCCCCCCEEEEC | 34.21 | 24719451 | |
| 26 | Phosphorylation | FRGFSSGSAVVSGGS CCCCCCCCEEEECCC | 21.60 | 30087585 | |
| 42 | Glutathionylation | RSTSSFSCLSRHGGG CCCCCCCCCCCCCCC | 3.63 | 24333276 | |
| 62 | Phosphorylation | GGGFGSRSLVGLGGT CCCCCCCCEEECCCC | 29.16 | 8077693 | |
| 71 | Phosphorylation | VGLGGTKSISISVAG EECCCCEEEEEEEEC | 22.77 | 20860994 | |
| 73 | Phosphorylation | LGGTKSISISVAGGG CCCCEEEEEEEECCC | 18.85 | 20860994 | |
| 75 | Phosphorylation | GTKSISISVAGGGGG CCEEEEEEEECCCCC | 10.10 | - | |
| 183 | Ubiquitination | AQEREQIKTLNNKFA HHHHHHHHHHHHHHH | 46.80 | 22817900 | |
| 184 | Phosphorylation | QEREQIKTLNNKFAS HHHHHHHHHHHHHHH | 36.03 | 24719451 | |
| 188 | Neddylation | QIKTLNNKFASFIDK HHHHHHHHHHHHHHH | 41.03 | 32015554 | |
| 188 | Ubiquitination | QIKTLNNKFASFIDK HHHHHHHHHHHHHHH | 41.03 | 21963094 | |
| 188 | Sumoylation | QIKTLNNKFASFIDK HHHHHHHHHHHHHHH | 41.03 | - | |
| 188 | Methylation | QIKTLNNKFASFIDK HHHHHHHHHHHHHHH | 41.03 | 132985 | |
| 188 | Sumoylation | QIKTLNNKFASFIDK HHHHHHHHHHHHHHH | 41.03 | - | |
| 188 | Acetylation | QIKTLNNKFASFIDK HHHHHHHHHHHHHHH | 41.03 | 132985 | |
| 189 | Ubiquitination | IKTLNNKFASFIDKV HHHHHHHHHHHHHHH | 8.17 | 21890473 | |
| 191 | Phosphorylation | TLNNKFASFIDKVRF HHHHHHHHHHHHHHH | 26.35 | 28355574 | |
| 194 | Ubiquitination | NKFASFIDKVRFLEQ HHHHHHHHHHHHHHH | 41.19 | 21890473 | |
| 195 | Ubiquitination | KFASFIDKVRFLEQQ HHHHHHHHHHHHHHH | 30.41 | 21963094 | |
| 195 | Acetylation | KFASFIDKVRFLEQQ HHHHHHHHHHHHHHH | 30.41 | 7705745 | |
| 201 | Ubiquitination | DKVRFLEQQNQVLQT HHHHHHHHHHHHHHH | 50.07 | 21890473 | |
| 264 | Phosphorylation | MQDLVEDYKKKYEDE HHHHHHHHHHHHHHH | 15.94 | - | |
| 265 | Acetylation | QDLVEDYKKKYEDEI HHHHHHHHHHHHHHH | 55.93 | 7481293 | |
| 267 | Ubiquitination | LVEDYKKKYEDEINK HHHHHHHHHHHHHHH | 50.12 | 20972266 | |
| 267 | Neddylation | LVEDYKKKYEDEINK HHHHHHHHHHHHHHH | 50.12 | 32015554 | |
| 347 | Phosphorylation | SRNLDLDSIIAEVKA CCCCCHHHHHHHHHH | 24.16 | 26657352 | |
| 356 | Phosphorylation | IAEVKAQYEEIAQRS HHHHHHHHHHHHHHC | 22.01 | 26356563 | |
| 418 | Ubiquitination | AHVKKQCKNVQDAIA HHHHHHHCCHHHHHH | 58.63 | 21853274 | |
| 463 | Phosphorylation | LARLLRDYQELMNVK HHHHHHHHHHHHCHH | 9.46 | 20068231 | |
| 482 | Ubiquitination | VEIATYRKLLEGEEC HHHHHHHHHHCCCCC | 47.19 | 22817900 | |
| 490 | Methylation | LLEGEECRMSGDLSS HHCCCCCCCCCCCCC | 26.11 | - | |
| 496 | Phosphorylation | CRMSGDLSSNVTVSV CCCCCCCCCCEEEEE | 25.30 | 23532336 | |
| 524 | Methylation | AFGGSGGRGSSSGGG CCCCCCCCCCCCCCC | 45.40 | 115385381 | |
| 526 | Phosphorylation | GGSGGRGSSSGGGYS CCCCCCCCCCCCCCC | 21.70 | 28857561 | |
| 527 | Phosphorylation | GSGGRGSSSGGGYSS CCCCCCCCCCCCCCC | 35.51 | 28857561 | |
| 528 | Phosphorylation | SGGRGSSSGGGYSSG CCCCCCCCCCCCCCC | 43.06 | - | |
| 536 | Phosphorylation | GGGYSSGSSSYGSGG CCCCCCCCCCCCCCC | 20.33 | 17192257 | |
| 546 | Phosphorylation | YGSGGRQSGSRGGSG CCCCCCCCCCCCCCC | 37.06 | - | |
| 548 | Phosphorylation | SGGRQSGSRGGSGGG CCCCCCCCCCCCCCC | 32.76 | - | |
| 552 | Phosphorylation | QSGSRGGSGGGGSIS CCCCCCCCCCCCCCC | 36.77 | 20860994 | |
| 557 | Phosphorylation | GGSGGGGSISGGGYG CCCCCCCCCCCCCCC | 19.49 | 17192257 | |
| 557 | O-linked_Glycosylation | GGSGGGGSISGGGYG CCCCCCCCCCCCCCC | 19.49 | 26853435 | |
| 563 | Phosphorylation | GSISGGGYGSGGGSG CCCCCCCCCCCCCCC | 16.05 | - | |
| 565 | Phosphorylation | ISGGGYGSGGGSGGR CCCCCCCCCCCCCCC | 26.27 | 22817900 | |
| 569 | Phosphorylation | GYGSGGGSGGRYGSG CCCCCCCCCCCCCCC | 41.15 | 20860994 | |
| 569 | O-linked_Glycosylation | GYGSGGGSGGRYGSG CCCCCCCCCCCCCCC | 41.15 | 26853435 | |
| 573 | Phosphorylation | GGGSGGRYGSGGGSK CCCCCCCCCCCCCCC | 20.93 | 30576142 | |
| 579 | O-linked_Glycosylation | RYGSGGGSKGGSISG CCCCCCCCCCCCCCC | 31.25 | 26853435 | |
| 579 | Phosphorylation | RYGSGGGSKGGSISG CCCCCCCCCCCCCCC | 31.25 | 24275569 | |
| 589 | Phosphorylation | GSISGGGYGSGGGKH CCCCCCCCCCCCCCC | 16.05 | 28857561 | |
| 591 | Phosphorylation | ISGGGYGSGGGKHSS CCCCCCCCCCCCCCC | 26.27 | 28857561 | |
| 597 | Phosphorylation | GSGGGKHSSGGGSRG CCCCCCCCCCCCCCC | 33.88 | 25954137 | |
| 598 | Phosphorylation | SGGGKHSSGGGSRGG CCCCCCCCCCCCCCC | 40.97 | 24275569 | |
| 602 | Phosphorylation | KHSSGGGSRGGSSSG CCCCCCCCCCCCCCC | 30.90 | 25954137 | |
| 606 | Phosphorylation | GGGSRGGSSSGGGYG CCCCCCCCCCCCCCC | 24.93 | 25954137 | |
| 607 | Phosphorylation | GGSRGGSSSGGGYGS CCCCCCCCCCCCCCC | 35.96 | 20562096 | |
| 608 | Phosphorylation | GSRGGSSSGGGYGSG CCCCCCCCCCCCCCC | 43.06 | 22817900 | |
| 614 | Phosphorylation | SSGGGYGSGGGGSSS CCCCCCCCCCCCCCC | 26.27 | 22817900 | |
| 620 | Phosphorylation | GSGGGGSSSVKGSSG CCCCCCCCCCCCCCC | 42.28 | - | |
| 621 | Phosphorylation | SGGGGSSSVKGSSGE CCCCCCCCCCCCCCC | 29.55 | - | |
| 635 | Phosphorylation | EAFGSSVTFSFR--- CCCCCCEEEEEC--- | 18.60 | 20562096 | |
| 637 | Phosphorylation | FGSSVTFSFR----- CCCCEEEEEC----- | 15.67 | 25954137 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of K22E_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of K22E_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of K22E_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| K2C1_HUMAN | KRT1 | physical | 22939629 | |
| K1C13_HUMAN | KRT13 | physical | 25416956 | |
| K1C19_HUMAN | KRT19 | physical | 25416956 | |
| K1H1_HUMAN | KRT31 | physical | 25416956 | |
| KRT38_HUMAN | KRT38 | physical | 25416956 | |
| K1C40_HUMAN | KRT40 | physical | 25416956 | |
| K1C10_HUMAN | KRT10 | physical | 26344197 | |
| K2C5_HUMAN | KRT5 | physical | 26344197 | |
| K2C1B_HUMAN | KRT77 | physical | 26344197 | |
| TRY1_HUMAN | PRSS1 | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 146800 | Ichthyosis bullosa of Siemens (IBS) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-62; SER-536 AND SER-557,AND MASS SPECTROMETRY. | |